Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
15.22
-0.11 (-0.72%)
At close: Apr 28, 2026, 4:00 PM EDT
15.30
+0.08 (0.53%)
After-hours: Apr 28, 2026, 7:57 PM EDT
Mesoblast Market Cap
Mesoblast has a market cap or net worth of $2.00 billion as of April 28, 2026. Its market cap has increased by 66.74% in one year.
Market Cap
2.00B
Enterprise Value
2.00B
1-Year Change
66.74%
Ranking
Category
Stock Price
$15.22
Market Cap Chart
Since November 13, 2015, Mesoblast's market cap has increased from $593.20M to $2.00B, an increase of 236.88%. That is a compound annual growth rate of 12.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.98B | -14.46% |
| Dec 31, 2025 | 2.31B | 2.14% |
| Dec 31, 2024 | 2.26B | 1,162.26% |
| Dec 29, 2023 | 179.10M | -58.22% |
| Dec 30, 2022 | 428.70M | -31.15% |
| Dec 31, 2021 | 622.70M | -37.40% |
| Dec 31, 2020 | 994.70M | 35.19% |
| Dec 31, 2019 | 735.80M | 84.92% |
| Dec 31, 2018 | 397.90M | -27.59% |
| Dec 29, 2017 | 549.50M | 34.55% |
| Dec 30, 2016 | 408.40M | -12.21% |
| Dec 31, 2015 | 465.20M | -21.58% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adaptive Biotechnologies | 2.18B |
| Sarepta Therapeutics | 2.13B |
| Aurinia Pharmaceuticals | 2.12B |
| Zymeworks | 2.07B |
| Ocular Therapeutix | 2.07B |
| Capricor Therapeutics | 2.04B |
| Trevi Therapeutics | 2.02B |
| Stoke Therapeutics | 2.01B |